Founded in 1993 and located in Beijing Economic and Technological Development Area, Beijing Kinghawk Pharmaceutical Co., Ltd is a hi-tech enterprise which covers 6000m2 and possesses 2000m2 GMP workshops, and is ISO13485 certified by TUV in 2006 and GMP certified by SFDA in 2003, specialized in research, development and production of in-vitro diagnostic reagents in China.

Over a decade of development, KINGHAWK has been transformed into one of the leading IVD companies in China. Now, over 80 kinds of in-vitro diagnosis products of ELISA series, clinical chemistry reagents series, rapid detection series, PCR series and blood grouping series are manufactured and marked through out of China. With its systematic products and professional services, a good direct sale and service network and effective channels have been established around the country. KINGHAWK's sincerely customers range in China CDC, large hospitals, blood stations, and scientific research institutes.

Besides, KINGHAWK has actively undertaken several state-level research projects such as AIDS confirmation reagent originated by Ministry of Health of the P. R.China and biological antiterrorism projects originated by the Academy of Military Medical Sciences. By cooperating with foreign enterprises in Europe, North America, Japan and Australia, KINGHAWK has set up extensive technical exchange channels with the new development of the Diagnostic industry and kept the same pace with global science and technology.